These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 2957047
1. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy. Nelson JS, Roberts WG, Berns MW. Cancer Res; 1987 Sep 01; 47(17):4681-5. PubMed ID: 2957047 [Abstract] [Full Text] [Related]
2. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Wong Kee Song LM, Wang KK, Zinsmeister AR. Cancer; 1998 Jan 15; 82(2):421-7. PubMed ID: 9445202 [Abstract] [Full Text] [Related]
3. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Ferrario A, Kessel D, Gomer CJ. Cancer Res; 1992 May 15; 52(10):2890-3. PubMed ID: 1581904 [Abstract] [Full Text] [Related]
4. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse. Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H. Oral Oncol; 2006 Jan 15; 42(1):46-50. PubMed ID: 16266818 [Abstract] [Full Text] [Related]
5. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study. Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T. Anticancer Res; 2003 Jan 15; 23(6C):4897-900. PubMed ID: 14981942 [Abstract] [Full Text] [Related]
6. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Gomer CJ, Ferrario A. Cancer Res; 1990 Jul 01; 50(13):3985-90. PubMed ID: 2354446 [Abstract] [Full Text] [Related]
7. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor. Webber J, Leeson B, Fromm D, Kessel D. J Photochem Photobiol B; 2005 Feb 01; 78(2):135-40. PubMed ID: 15664500 [Abstract] [Full Text] [Related]
8. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Taber SW, Fingar VH, Coots CT, Wieman TJ. Clin Cancer Res; 1998 Nov 01; 4(11):2741-6. PubMed ID: 9829737 [Abstract] [Full Text] [Related]
9. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. McMahon KS, Wieman TJ, Moore PH, Fingar VH. Cancer Res; 1994 Oct 15; 54(20):5374-9. PubMed ID: 7923168 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Chan AL, Juarez M, Allen R, Volz W, Albertson T. Photodermatol Photoimmunol Photomed; 2005 Apr 15; 21(2):72-8. PubMed ID: 15752124 [Abstract] [Full Text] [Related]
11. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative. El-Far M, Pimstone N. Prog Clin Biol Res; 1984 Apr 15; 170():661-72. PubMed ID: 6241706 [Abstract] [Full Text] [Related]
12. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries. Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S. Lasers Surg Med; 2001 Apr 15; 28(4):381-8. PubMed ID: 11344521 [Abstract] [Full Text] [Related]
13. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro. Sheyhedin I, Aizawa K, Araake M, Kumasaka H, Okunaka T, Kato H. Photochem Photobiol; 1998 Jul 15; 68(1):110-4. PubMed ID: 9679456 [Abstract] [Full Text] [Related]
14. [A basic study of photodynamic therapy of experimental hepatoma with ME 2906]. Nakamura J, Kajiwara H, Nakamura M, Watanabe M, Naganuma K, Tanaka H, Usui S, Sumiyama Y, Saito K, Aizawa K. Gan To Kagaku Ryoho; 1998 Jul 15; 25(9):1454-6. PubMed ID: 9703852 [Abstract] [Full Text] [Related]
15. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model. Kaneko T, Chiba H, Yasuda T, Kusama K. Oral Oncol; 2004 Sep 15; 40(8):787-92. PubMed ID: 15288832 [Abstract] [Full Text] [Related]
16. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6). Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM. Ophthalmology; 1999 Jul 15; 106(7):1384-91. PubMed ID: 10406627 [Abstract] [Full Text] [Related]
17. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6]. Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y. Nippon Ganka Gakkai Zasshi; 1997 Feb 15; 101(2):134-40. PubMed ID: 9124093 [Abstract] [Full Text] [Related]
18. Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6). Yumita N, Iwase Y, Nishi K, Ikeda T, Komatsu H, Fukai T, Onodera K, Nishi H, Takeda K, Umemura S, Okudaira K, Momose Y. Anticancer Res; 2011 Feb 15; 31(2):501-6. PubMed ID: 21378330 [Abstract] [Full Text] [Related]
19. Photodynamic effect using a diode laser with mono-l-aspartyl chlorin e6 (NPe6) for implanted mouse tumor. Katsumi T, Kato H, Okunaka T, Kuroiwa Y, Yoshiteru I, Saito K, Konaka C, Aizawa K. J Clin Laser Med Surg; 1994 Aug 15; 12(4):211-3. PubMed ID: 10147480 [Abstract] [Full Text] [Related]
20. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components. Nelson JS, Wright WH, Berns MW. J Natl Cancer Inst; 1985 Dec 15; 75(6):1135-40. PubMed ID: 2933546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]